Link copied to your clipboard

Stay connected to current HRS-AKI information

How changes in guidance are driving earlier diagnosis

In this featured CLINTOPICS™ presentation, learn how recent changes to guidelines can help align hepatologists and nephrologists, leading to earlier diagnosis of HRS-AKI.

Roundtable Discussion With:

Todd Frederick, MD

Transplant Hepatologist,

California Pacific Medical Center, Sutter Health

Kevin R. Regner, MD, MS

Professor of Medicine

Chief, Division of Nephrology

Medical College of Wisconsin

Empower early diagnosis

Early diagnosis and intervention of HRS-AKI can help establish a foundation for positive transplant outcomes. A quick way to reinforce how to diagnose HRS-AKI earlier starts with “CARE.” Download this handy tool to help your team and colleagues within your health system spot the symptoms faster.

The impact of MELD on liver transplantation

Hot topics in the transplant community

To help you keep up with the growing literature about HRS, we have links to selected recent articles. These papers explore aspects relevant to transplant success and evolution of the management of HRS-AKI.

Download

Making the rounds

This poll is a way to gauge how others in the transplant community are thinking about diagnosing, treating, or managing HRS-AKI.

Last month the poll asked:"On average, what percentage of HRS-AKI patients admitted to your institution will be eligible for a liver transplant?"

Respondents answered:

<10% 50%

10%-20% 37.5%

>20%-30% 12.5%

>30% 0%

Access expert advice on HRS-AKI diagnosis and management

Keep abreast of what is changing in the HRS-AKI treatment landscape that can impact your liver and kidney transplantation efforts. Review recommendations for the diagnosis, management, and treatment of HRS-AKI from leading organizations.

Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA)

Acute kidney injury in patients with cirrhosis: Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting [Jul 2024]

American Association for the Study of Liver Diseases (AASLD)

AASLD practice guidance on acute-on-chronic liver failure and the management of critically ill patients with cirrhosis [Jun 2024]

American Gastroenterological Association (AGA)

AGA clinical practice update on the use of vasoactive drugs and intravenous albumin in cirrhosis: expert review [Jan 2024]

American College of Gastroenterology (ACG)

Acute-on-chronic liver failure clinical guidelines [Feb 2022]

American Association for the Study of Liver Diseases (AASLD)

Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association for the Study of Liver Diseases [Aug 2021]

HRS-AKI, hepatorenal syndrome–acute kidney injury; MELD, Model for End-Stage Liver Disease.